US Bancorp’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.7K | Sell |
11,000
-600
| -5% | -$858 | ﹤0.01% | 3258 |
|
|
2025
Q1 | $18.6K | Buy |
11,600
+11,544
| +20,614% | +$18.5K | ﹤0.01% | 3190 |
|
|
2024
Q4 | $202 | Buy |
56
+18
| +47% | +$65 | ﹤0.01% | 4076 |
|
|
2024
Q3 | $217 | Buy |
+38
| New | +$217 | ﹤0.01% | 3986 |
|
|
2024
Q2 | – | Sell |
-39
| Closed | -$319 | – | 3970 |
|
|
2024
Q1 | $319 | Buy |
+39
| New | +$319 | ﹤0.01% | 3870 |
|
|
2022
Q2 | – | Sell |
-118
| Closed | -$3K | – | 4061 |
|
|
2022
Q1 | $3K | Buy |
+118
| New | +$3K | ﹤0.01% | 3696 |
|